Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Welch Center for Prevention, Epidemiology, & Clinical Research, Johns Hopkins University, Baltimore, MD, USA.
J Gen Intern Med. 2022 Dec;37(16):4112-4119. doi: 10.1007/s11606-022-07412-9. Epub 2022 Mar 2.
The incidence of diabetes in the general US population (6.7 per 1000 adults in 2018) has not changed significantly since 2000, suggesting that individuals with prediabetes are not connecting to evidence-based interventions.
We sought to describe the clinical care of individuals with prediabetes, determine patient factors associated with this care, and evaluate risk for diabetes development.
Retrospective cohort study using linked claims and electronic health record data.
We created a cohort of adults with prediabetes based on laboratory measures. We excluded patients with a prior history of diabetes, pregnancy in prior 6 months, or recent steroid use.
We measured ordering and completion of clinical services targeting prediabetes management and diabetes incidence within 12 months following cohort entry. We tested the strength of the association between individuals' characteristics and outcomes of interest using bivariate and multiple logistic regression.
Our cohort included 3888 patients with a laboratory diagnosis of prediabetes (incident or prevalent prediabetes). Within 12 months, 63.4% had repeat glycemic testing, yet only 10.4% had coded diagnoses of prediabetes, 1.0% were referred for nutrition services, and 5.4% were prescribed metformin. Most patients completed labs and nutrition visits when referred and filled metformin when prescribed. Individuals with a higher glycemic level or BMI were more likely to receive prediabetes clinical care. Six percent of individuals developed diabetes within 12 months of cohort entry and had higher glycemic levels and BMI ≥ 30 kg/m. In the adjusted model, Black individuals had 1.4 times higher odds of developing diabetes than White individuals.
Rates of prediabetes clinical care activities are low and have not improved. Strategies are urgently needed to improve prediabetes care delivery thereby preventing or delaying incident diabetes.
自 2000 年以来,美国普通人群(2018 年每 1000 名成年人中有 6.7 人)的糖尿病发病率没有显著变化,这表明患有前驱糖尿病的个体并未接触到基于证据的干预措施。
我们旨在描述前驱糖尿病患者的临床护理情况,确定与该护理相关的患者因素,并评估糖尿病发病风险。
使用链接索赔和电子健康记录数据的回顾性队列研究。
我们根据实验室检测结果创建了一个前驱糖尿病患者队列。我们排除了有既往糖尿病史、妊娠史(过去 6 个月内)或近期使用类固醇的患者。
我们测量了针对前驱糖尿病管理的临床服务的开具和完成情况,以及队列入组后 12 个月内的糖尿病发病情况。我们使用双变量和多变量逻辑回归来检验个体特征与感兴趣结局之间的关联强度。
我们的队列包括 3888 名实验室诊断为前驱糖尿病(新发病或既有前驱糖尿病)的患者。在 12 个月内,63.4%的患者进行了重复血糖检测,但仅有 10.4%的患者被诊断为前驱糖尿病,1.0%的患者被转介接受营养服务,5.4%的患者被开处二甲双胍。大多数患者在被转介后完成了实验室和营养就诊,在被开处二甲双胍后完成了用药。血糖水平或 BMI 较高的患者更有可能接受前驱糖尿病的临床护理。6%的患者在入组后 12 个月内患上了糖尿病,这些患者的血糖水平和 BMI≥30kg/m更高。在调整模型中,黑人患者患糖尿病的几率是白人患者的 1.4 倍。
前驱糖尿病临床护理活动的比例较低,且并未改善。迫切需要制定策略来改善前驱糖尿病的护理服务,从而预防或延迟糖尿病的发生。